Top Private Equity News, Member Posts, Managed Futures Daily Indices and more!

3yrs ago Private Equity privateequitywire Views: 332

EW GROUP acquires Hygiena from Warburg Pincus

Submitted 17/02/2021 - 10:04am

EW GROUP, a German strategic holding company in the field of animal breeding, health, nutrition and diagnostics, has acquired Hygiena, a specialist in food safety and environmental testing solutions. 

The terms of the transaction have not been disclosed. The transaction is expected to close in March 2021.

Hygiena, headquartered in Camarillo, California, USA, with nine locations around the world, develops, manufactures and distributes food safety and environmental diagnostic solutions. The products are sold in over 100 countries to more than 10,000 customers. For two decades, Hygiena has been committed to providing accurate and easy-to-use-diagnostic tests, supported by the most knowledgeable technical service teams in the industry.

"We have always been committed to providing the best-in-class diagnostics and customer support around the world. This new partnership with EW GROUP will accelerate our growth, enhance our global capabilities, and expand our portfolio of products for our customers," says Steven Nason, CEO of Hygiena. "I couldn't have imagined a better outcome for Hygiena and our Hygiena team. We are so excited to continue our mission within EW GROUP and look forward to joining forces with the BioChek and Biotecon teams. Warburg Pincus has been an amazing partner in our journey over the past four and a half years. I would like to thank them for their close partnership, invaluable contribution and strategic insight."

The newly formed group of companies, under the Hygiena umbrella, will include BioChek, a global veterinary diagnostic company, as well as Biotecon, an innovator in PCR, GMO, ID and environmental diagnostics. Both companies are subsidiaries of the EW GROUP, expanding Hygiena's food safety portfolio with attractive molecular diagnostic capabilities, sample preparation as well as the veterinary diagnostic field.

"We are extremely excited about welcoming Hygiena to EW GROUP. Due to the outstanding leadership of Steve Nason and his team, Hygiena has become a leading player in the food and environmental testing space," says Jan and Dirk Wesjohann, both Managing Directors at EW GROUP. "We are convinced that the combination of Hygiena with our existing diagnostic activities will create a basis for substantial future growth."

Thomas Struckmeyer, CEO of BioChek and Biotecon, is also enthusiastic: "With this acquisition and through the synergetic combination with our existing diagnostics businesses, we will create a leading player in food and veterinary diagnostics, providing a true 'One Health' approach from 'Farm to Fork' to the benefit of our global customer base."

As part of the partnership, EW GROUP and Hygiena are committed, based on the EW GROUP principles, to invest in new technologies, R&D and international structures. Technical expertise will be leveraged amongst the companies to develop new products in diagnostics, accelerate development and further improve data interpretation and management software capabilities.

"We are excited for Hygiena's next chapter of growth and know that they will continue to thrive in combination with EW GROUP, a partner that shares the same values, ensures a positive future for the entire Hygiena team and lays the foundation for an excellent outlook for future business development," adds Stephanie Geveda, Managing Director, Head of Business Services, Warburg Pincus.

Houlihan Lokey and Citi served as financial advisors and Cleary Gottlieb Steen & Hamilton LLP served as legal advisor to Hygiena. Sidley Austin LLP and Moulton | Moore | Stella LLP acted as legal counsel for EW GROUP.

Author Profile Tags Deals & Transactions Acquisitions

Today's Private Equity Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.